pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
BIOMARIN PHARMACEUTICAL INC ($BMRN) · news · pharmadog
← back to BIOMARIN PHARMACEUTICAL INC
News mentioning $BMRN
12
stories
2d
Foghorn cuts 40% of workforce
biospace
4d
The top 12 companies hiring in biopharma now
biospace
Sep 2, 26
Teva claims success in celiac study; BioMarin, Ascendis settle patent dispute
biopharma dive
Aug 31, 26
Biomarin nabs big royalties in achondroplasia patent settlement with Ascendis
biospace
Aug 20, 26
7 biopharma M&A deals where layoffs followed
biospace
Aug 18, 26
BioMarin acquires experimental drug for rare bone disorder in $275M deal
biopharma dive
Aug 18, 26
BioMarin bulks up bone unit with $275M Alesta buyout to challenge AstraZeneca
fiercebiotech
Aug 12, 26
Silence cashes in on ‘differentiated’ data; UK reaffirms support for childhood vaccines
biopharma dive
Aug 10, 26
BioMarin axes asset from $270M Inozyme takeover, ending run in rare metabolic indication
biospace
Aug 7, 26
BioMarin axes $270M rare disease asset after missing phase 3 endpoint
fiercebiotech
Jul 16, 26
Spurred by deep cuts and M&A activity, H1 layoffs could oust 14,000+ in biopharma
biospace
May 19, 26
BioMarin drug acquired in buyout misses goal in rare disease study
biopharma dive
